SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.68-2.4%Dec 12 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (227)6/16/1999 12:01:00 AM
From: mike head  Read Replies (1) of 52153
 
Rick. Appreciate your feedback. A cursory review of their Web page--- {Sure enough, He *does* walk on water!!} About Alusuisse-Lonzo; why, sure enough they're both headquartered in CH, sorta, but are highly diversified conglomerates... Lonzo has a deal with Genzyme transgenics, but manufactures chemical 'specialties' all over the world!(even Texas!) There appears to be some relationship with Alusuisse, who makes composite building 'skin', but no connection with Celltech. So Celltech does put it's annual report on-line; all 51 pages of it! My take- (And remembering that HE walks on water), and I'm an architect--not a biologist, is that it seems to be sort of a hybrid British composite of IMNX, CENTO, & PDLI, at least in sofar as their primary platform is MAb's and they're persuing all the same indications as their US brethern noted above. Sorry- not much help... If anybody wants to wade through 51 pages of AR, it's here>>>

celltech.co.uk

The rest is silence! God Bless
Pax et Bonum, mch
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext